Subscribe To
PCSA / Processa Pharmaceuticals to Present at the ThinkEquity Conference
PCSA News
By GlobeNewsWire
October 13, 2023
Processa Pharmaceuticals to Present at the ThinkEquity Conference
HANOVER, MD, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage p more_horizontal
By GlobeNewsWire
August 10, 2023
Processa Pharmaceuticals to Present at the Sidoti & Co. Micro Cap Virtual Conference
HANOVER, MD, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage p more_horizontal
By GlobeNewsWire
April 28, 2023
Processa Pharmaceuticals to Present PCS12852 Gastroparesis Results at the Digestive Disease Week 2023 Annual Meeting
HANOVER, MD, April 28, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage more_horizontal
By Zacks Investment Research
April 6, 2023
Heatwurx Inc. (PCSA) Upgraded to Buy: Here's What You Should Know
Heatwurx Inc. (PCSA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive more_horizontal
By Seeking Alpha
May 14, 2022
Processa Pharmaceuticals' (PCSA) CEO David Young on Q1 2022 Results - Earnings Call Transcript
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Jim Stanker – Chief Fina more_horizontal
By Seeking Alpha
March 30, 2022
Processa Pharmaceuticals' (PCSA) CEO David Young on Q4 2021 Results - Earnings Call Transcript
Processa Pharmaceuticals' (PCSA) CEO David Young on Q4 2021 Results - Earnings Call Transcript more_horizontal
By GlobeNewsWire
March 23, 2022
Processa Pharmaceuticals To Host Conference Call to Discuss Fourth Quarter 2021 Results and Provide Drug Development Update on March 30 at 4:30 p.m. EST
HANOVER, MD, March 23, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical stage biopharmaceutical company developing p more_horizontal
By Seeking Alpha
November 11, 2021
Processa Pharmaceuticals' (PCSA) CEO David Young on Q3 2021 Results - Earnings Call Transcript
Processa Pharmaceuticals' (PCSA) CEO David Young on Q3 2021 Results - Earnings Call Transcript more_horizontal